Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Verve Therapeutics Inc (VERV)

Verve Therapeutics Inc (VERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 575,299
  • Shares Outstanding, K 83,619
  • Annual Sales, $ 11,760 K
  • Annual Income, $ -200,070 K
  • 60-Month Beta 1.70
  • Price/Sales 49.14
  • Price/Cash Flow N/A
  • Price/Book 0.91
Trade VERV with:

Options Overview Details

View History
  • Implied Volatility 93.48% ( -79.30%)
  • Historical Volatility 129.66%
  • IV Percentile 64%
  • IV Rank 26.83%
  • IV High 233.36% on 10/20/23
  • IV Low 42.19% on 06/12/23
  • Put/Call Vol Ratio 0.10
  • Today's Volume 55
  • Volume Avg (30-Day) 302
  • Put/Call OI Ratio 0.73
  • Today's Open Interest 6,941
  • Open Int (30-Day) 6,548

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.68
  • Number of Estimates 5
  • High Estimate -0.56
  • Low Estimate -0.79
  • Prior Year -0.84
  • Growth Rate Est. (year over year) +19.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.42 +3.12%
on 04/19/24
13.63 -51.43%
on 03/28/24
-6.35 (-48.96%)
since 03/22/24
3-Month
6.42 +3.12%
on 04/19/24
19.34 -65.77%
on 02/29/24
-4.84 (-42.23%)
since 01/24/24
52-Week
6.42 +3.12%
on 04/19/24
21.42 -69.09%
on 06/16/23
-9.40 (-58.68%)
since 04/24/23

Most Recent Stories

More News
After a Serious Setback, Is Verve Therapeutics a Buy?

There are a few silver linings at play here.

VERV : 6.57 (-4.51%)
Stocks Close Lower on Fears Fed Rate Cuts Will be Delayed

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.72%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -1.00%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.94%. Stock indexes...

$SPX : 5,060.14 (-0.21%)
SPY : 505.16 (-0.10%)
$DOWI : 38,417.30 (-0.22%)
DIA : 384.32 (-0.18%)
$IUXX : 17,479.61 (+0.05%)
QQQ : 426.11 (+0.24%)
^BTCUSD : 64,112.73 (-3.21%)
ZNM24 : 107-250 (-0.27%)
HUM : 316.62 (-3.46%)
CVS : 67.80 (-1.02%)
UNH : 486.94 (+0.16%)
CNC : 76.01 (+0.22%)
Stocks Fall as Bond Yields Climb on Strong US Economic News

The S&P 500 Index ($SPX ) (SPY ) this morning is down -1.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.51%. Stock indexes this...

$SPX : 5,060.14 (-0.21%)
SPY : 505.16 (-0.10%)
$DOWI : 38,417.30 (-0.22%)
DIA : 384.32 (-0.18%)
$IUXX : 17,479.61 (+0.05%)
QQQ : 426.11 (+0.24%)
^BTCUSD : 64,112.73 (-3.21%)
ZNM24 : 107-250 (-0.27%)
HUM : 316.62 (-3.46%)
CVS : 67.80 (-1.02%)
UNH : 486.94 (+0.16%)
CNC : 76.01 (+0.22%)
Stocks Retreat as Bond Yields Jump on Diminished Fed Rate Cut Prospects

The S&P 500 Index ($SPX ) (SPY ) this morning is down -1.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.47%. Stock indexes this...

$SPX : 5,060.14 (-0.21%)
SPY : 505.16 (-0.10%)
$DOWI : 38,417.30 (-0.22%)
DIA : 384.32 (-0.18%)
$IUXX : 17,479.61 (+0.05%)
QQQ : 426.11 (+0.24%)
ZNM24 : 107-250 (-0.27%)
HUM : 316.62 (-3.46%)
CVS : 67.80 (-1.02%)
UNH : 486.94 (+0.16%)
ELV : 532.86 (-0.01%)
CNC : 76.01 (+0.22%)
2 Risky Gene-Editing Stocks to Buy in the New Bull Market if You Dare

It's less scary to take on risky investments when the market is rising.

CRBU : 3.83 (-3.77%)
VERV : 6.57 (-4.51%)
Why Beam Therapeutics Stock Zoomed 17% Higher Today

JPMorgan Chase becomes the latest institution in the company's bull pen.

VERV : 6.57 (-4.51%)
LLY : 731.81 (-1.86%)
BEAM : 22.81 (-2.81%)
JPM : 192.55 (+0.21%)
2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics

Curing rare inherited illnesses could be a lucrative business model.

CRSP : 55.77 (-1.13%)
NTLA : 21.18 (-1.63%)
VERV : 6.57 (-4.51%)
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.

The gene-editing revolution is unfolding at a record pace. Still, risks abound, and picking individual stocks may not be the wisest approach.

CRSP : 55.77 (-1.13%)
BEAM : 22.81 (-2.81%)
CRBU : 3.83 (-3.77%)
EDIT : 5.32 (-2.56%)
NTLA : 21.18 (-1.63%)
PRME : 4.70 (-2.08%)
VERV : 6.57 (-4.51%)
LLY : 731.81 (-1.86%)
REGN : 908.19 (+0.10%)
VRTX : 401.78 (-0.77%)
ARKG : 23.68 (-1.25%)
HOOD : 17.22 (-2.27%)
Why Verve Therapeutics Stock Crashed as Much as 30% This Week

There was a concerning development in the company's clinical trials.

VERV : 6.57 (-4.51%)
Verve Therapeutics: Why Great Results Aren't Enough

The company's twist on CRISPR appears to work as intended but that didn't stop this biotech's stock price from collapsing.

VERV : 6.57 (-4.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Verve Therapeutics is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's lead product candidate includes VERVE-101. Verve Therapeutics is based in CAMBRIDGE,...

See More

Key Turning Points

3rd Resistance Point 7.86
2nd Resistance Point 7.63
1st Resistance Point 7.26
Last Price 6.57
1st Support Level 6.66
2nd Support Level 6.43
3rd Support Level 6.06

See More

52-Week High 21.42
Fibonacci 61.8% 15.69
Fibonacci 50% 13.92
Fibonacci 38.2% 12.15
Last Price 6.57
52-Week Low 6.42

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar